WHAT WE DO
Health Decisions is a full-service CRO providing extensive clinical development expertise and comprehensive services for bringing women’s health and diagnostics to market rapidly, efficiently and with minimal risk.
SERVICES
Trial Management
Trial Management
Health Decisions provides proactive project management for phase 1 – 4 trials of women’s health drugs as well as trials of devices and diagnostics for all therapeutic areas.
Monitoring
Monitoring
The Health Decisions approach to monitoring clinical trials involves teamwork between field CRAs and in-house CRAs to ensure high data-quality and improve site performance.
Data Management and Biometrics
Data Management and Biometrics
The highly experienced Health Decisions data management group offers a choice of three EDC systems and tailors recommendations to each sponsor and study.
Regulatory and Quality
Regulatory and Quality
Health Decisions offers extensive regulatory and quality assurance services, from strategic counsel and pre-IND and pre-IDE meetings through marketing submissions.
Study Design and Protocol Development
Study Design and Protocol Development
The Health Decisions biometrics group has extensive expertise in protocol development for phase 1 – 4 trials of therapeutics as well as diagnostics trials.
LiveTrial EDC
LiveTrial EDC
Health Decisions offers its FISMA-compliant LiveTrial Data Management as a service — a practical solution for maintaining eligibility for federal contracts.
A WORD FROM THE CEO:
“We are committed to building the world’s leading CRO in women’s health and diagnostics. Health Decisions has collaborated effectively with many innovative sponsors of women’s health and diagnostic products. We are truly passionate about improving women’s health and interested in learning how we can bring your product to market rapidly with minimal cost and risk. We are equally passionate about assisting diagnostics developers in efficiently demonstrating the clinical validity and utility of their products.”
Patrick Phillips, BSc (Hons), D.Phil., Chief Executive Officer
What Women’s Health Means to Us
The Importance of Diagnostics to Health Decisions
- Health Decisions’ CMO Andrea Lukes Accepts Health Care Heroes Award HDauthor 2018-03-12T14:46:00+00:00
Health Decisions’ CMO Andrea Lukes Accepts Health Care Heroes Award
- Health Decisions’ CMO Andrea Lukes Named a Health Care Hero HDauthor 2018-02-02T17:59:53+00:00
Health Decisions’ CMO Andrea Lukes Named a Health Care Hero
- Health Decisions Hosts Webinar on Critical Success Factors in Reproductive Health Studies HDauthor 2018-01-18T16:17:59+00:00
Health Decisions Hosts Webinar on Critical Success Factors in Reproductive Health Studies
- Health Decisions’ Webinar Offers Key Tips for Diagnostics Developers in 2018 and Beyond HDAuthor 2017-12-05T20:42:53+00:00
Health Decisions’ Webinar Offers Key Tips for Diagnostics Developers in 2018 and Beyond
- CRO Health Decisions Announces Women’s Health Initiative HDAuthor 2017-10-03T21:26:02+00:00
CRO Health Decisions Announces Women’s Health Initiative
- CRO Health Decisions Names Andrea Lukes, MD, FACOG, CMO HDAuthor 2017-10-03T21:26:21+00:00
CRO Health Decisions Names Andrea Lukes, MD, FACOG, CMO
- CRO Health Decisions Exhibits and Presents at DIA 2017 HDAuthor 2017-10-03T21:36:07+00:00
CRO Health Decisions Exhibits and Presents at DIA 2017
- International Society for the Study of Women’s Sexual Health Annual Meeting 2018 February 8 – 11, San Diego, CA HDauthor 2017-12-12T18:17:50+00:00
International Society for the Study of Women’s Sexual Health Annual Meeting 2018 February 8 – 11, San Diego, CA
- Molecular Med Tri-Conference February 11-16, 2018 San Francisco CA HDAuthor 2017-12-12T18:18:43+00:00
Molecular Med Tri-Conference February 11-16, 2018 San Francisco CA
- SCOPE: Summit for Clinical Ops Executives February 12-15, 2018, Orlando, FL HDAuthor 2017-12-13T14:31:24+00:00
SCOPE: Summit for Clinical Ops Executives February 12-15, 2018, Orlando, FL
- National Eating Disorder Awareness Week Feb 23 – Mar 1, 2018 HDAuthor 2017-12-12T18:21:05+00:00
National Eating Disorder Awareness Week Feb 23 – Mar 1, 2018
- March 2018: Endometriosis Awareness Month HDAuthor 2017-12-12T18:22:12+00:00
March 2018: Endometriosis Awareness Month
- Society for Reproductive Investigation 65th Annual Scientific Meeting Mar 7 – 10, 2018, San Diego, CA HDauthor 2017-12-13T14:41:06+00:00
Society for Reproductive Investigation 65th Annual Scientific Meeting Mar 7 – 10, 2018, San Diego, CA
- Society of Gynecologic Oncology Annual Meeting on Women’s Cancer Mar 24 – 27, 2018, New Orleans, LA HDauthor 2017-12-13T14:42:00+00:00
Society of Gynecologic Oncology Annual Meeting on Women’s Cancer Mar 24 – 27, 2018, New Orleans, LA
- American College of Obstetricians and Gynecologists 2018 Annual Clinical and Scientific Meeting Apr 27 -30, Austin, TX HDauthor 2017-12-13T14:32:53+00:00
American College of Obstetricians and Gynecologists 2018 Annual Clinical and Scientific Meeting Apr 27 -30, Austin, TX
- May 2018: National Osteoporosis Awareness and Prevention Month HDAuthor 2017-12-12T18:25:57+00:00
May 2018: National Osteoporosis Awareness and Prevention Month
- May 2018: Celiac Disease Awareness Month HDAuthor 2017-12-12T18:26:42+00:00
May 2018: Celiac Disease Awareness Month
- DIA 2018 Annual Meeting June 24-28, Boston, MA HDAuthor 2017-12-13T14:36:35+00:00
DIA 2018 Annual Meeting June 24-28, Boston, MA
- Next Generation Dx Summit August 20 – 24, 2018, Washington, DC HDauthor 2017-12-12T18:28:42+00:00
Next Generation Dx Summit August 20 – 24, 2018, Washington, DC
- Annual Meeting of the North American Menopause Society Oct 3 – 6, 2018, San Diego, CA HDauthor 2017-12-13T14:30:50+00:00
Annual Meeting of the North American Menopause Society Oct 3 – 6, 2018, San Diego, CA
- American Society of Reproductive Medicine (ASRM) Scientific Congress & Expo 2018 October 6 – 10, Denver, CO HDAuthor 2017-12-12T18:29:54+00:00
American Society of Reproductive Medicine (ASRM) Scientific Congress & Expo 2018 October 6 – 10, Denver, CO
- Association for Molecular Pathology (AMP) 2018 Annual Meeting November 1 – 3, San Antonio, TX HDAuthor 2017-12-13T14:43:48+00:00
Association for Molecular Pathology (AMP) 2018 Annual Meeting November 1 – 3, San Antonio, TX
- Capabilities in Women’s Health Studies HDAuthor 2018-03-28T21:25:43+00:00
Capabilities in Women’s Health Studies
- Diagnostics Development Services HDAuthor 2018-03-28T21:24:49+00:00
Diagnostics Development Services
- Capabilities for Clinical Studies in Endometriosis HDauthor 2018-03-23T16:38:55+00:00
Capabilities for Clinical Studies in Endometriosis
- Large PMA Study of a Colorectal Cancer Diagnostic HDAuthor 2018-03-28T21:29:29+00:00
Large PMA Study of a Colorectal Cancer Diagnostic
- Dual 510(k)/CLIA Waiver Study of a POC Test HDAuthor 2018-03-28T21:30:12+00:00
Dual 510(k)/CLIA Waiver Study of a POC Test
- Addressing the New Imperative to Include Females in Clinical Trials HDAuthor 2018-03-28T21:35:40+00:00
Addressing the New Imperative to Include Females in Clinical Trials
- Nine Tips for Success in Precision Medicine HDAuthor 2018-03-28T21:32:57+00:00
Nine Tips for Success in Precision Medicine
- Ten Tips for Establishing the Clinical Utility of Molecular Diagnostics HDAuthor 2017-10-03T21:30:40+00:00
Ten Tips for Establishing the Clinical Utility of Molecular Diagnostics
- LiveTrial Data Management as a Service HDAuthor 2017-10-03T21:30:50+00:00
LiveTrial Data Management as a Service
- Perfecting Phase 2: Ten Essential Steps HDAuthor 2017-10-03T21:31:02+00:00
Perfecting Phase 2: Ten Essential Steps
- 510(k) Study of a Respiratory Diagnostic HDAuthor 2017-10-03T21:35:09+00:00
510(k) Study of a Respiratory Diagnostic
- Federal Contracting Capabilities Overview HDAuthor 2017-10-03T21:35:19+00:00
Federal Contracting Capabilities Overview
- Capabilities in Early Phase Studies HDAuthor 2017-10-03T21:35:28+00:00
Capabilities in Early Phase Studies
- Pivotal Study of an Alzheimer’s Drug HDAuthor 2017-10-03T21:37:17+00:00
Pivotal Study of an Alzheimer’s Drug
- Capabilities in Gastroenterology Studies HDAuthor 2017-10-03T21:37:27+00:00
Capabilities in Gastroenterology Studies
- Phase 2c: Expedited Development for All HDAuthor 2017-10-03T21:37:36+00:00
Phase 2c: Expedited Development for All
